業績

{ 178件 }

Yuki Oe, Hiroshi Nomoto, Akinobu Nakamura, Saki Kuwabara, Yuka Takahashi, Ayano Yasui, Rimi Izumihara, Aika Miya, Hiraku Kameda, Kyu Yong Cho, Tatsuya Atsumi, Hideaki Miyoshi Switching from insulin degludec plus dipeptidyl peptidase-4 inhibitor to insulin degludec/liraglutide improves glycemic variability in patients with type 2 diabetes: a preliminary prospective observation study J Diabetes Res, in press.

IF: 4.011

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Takahashi Y, Kameda H, Miya A, Nomoto H, Nakamura A, Nishimura H, Kimura H, Suzuki M, Konno S, Shimizu A, Matsuno Y, Okamoto M, Motegi H, Iwata N, Fujisawa H, Suzuki A, Sugimura Y, Miyoshi H, A tsumi T.

Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis.

Pituitary, in press.

IF: 4.107

  • 2022
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

Abe N, Kono Michihito, Kono Michihiro, Ohnishi N, Sato T, Tarumi M, Yoshimura M, Sato T, Karino K, Shimizu Y, Fujieda Y, Kato M, Hasebe R, Oku K, Murakami M, Atsumi T.

Glycogen synthase kinase 3β/CCR6-positive bone marrow cells correlate with disease activity in multicentric Castleman disease-TAFRO.

Br. J. Haematol. in press.

IF=6.998

  • 2021
  • 膠原病グループ
  • 欧文論文/原著

Atsumi T, Tanaka Y, Matsubara T, Amano K, Ishiguro N, Sugiyama E, Yamaoka K, Westhovens R, Ching D,  Messina OD, Burmester GR, Bartok B, Pechonkina A, Kondo S, Yin Z, Guo Y, Tasset C, Sundy JS, Takeuchi T Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3) Modern Rheumatology, in press.

IF: 3.023

  • 2021
  • 膠原病グループ
  • 欧文論文/原著

Oe Y, Kameda H, Nomoto H, Sakamoto K, Soyama T, Cho KY, Nakamura A, Iwasaki K, Abo D, Kudo K, Miyoshi H, Atsumi T.

Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor: a case report Medicine, in press

IF: 1.889

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/症例報告

47回日本神経内分泌学会 若手研究奨励賞 関崎 知紀先生

  • 2021
  • 糖尿病・内分泌グループ
  • 受賞

Watanabe-Kusunoki K, Nakazawa D, Yamamoto J, Matsuoka N, Kaneshima N, Nakagaki T, Yamamoto R, Maoka T, Iwasaki S, Tsuji T, Fukasawa Y, Nishimoto N, Nishio S, Atsumi T.

Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy.

Medicine, in press

IF: 1.889

  • 2021
  • 腎臓グループ
  • 欧文論文/原著

Kamoshima H, Nomoto H, Yamashita K, Takahashi Y, Tsuchida K, Kuwabara S, Miya A, Cho KY, Kameda H, Nakamura A, Atsumi T, Taneda S, Kurihara Y, Aoki S, Ono Y, Miyoshi H.

Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes?

Endocrine Journal, in press.

IF: 2.349

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Oba-Yamamoto C, Takeuchi J, Nakamura A, Nomoto H, Kameda H, Cho KY, Atsumi T, Miyoshi H Impact of low-starch high-fiber pasta on postprandial blood glucose.

Nutrition, Metabolism and Cardiovascular Diseases, in press.

IF: 4.222

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著

Kawata S, Nakamura A, Miyoshi H, Yang K, Shigesawa I, Yamauchi Y, Tsuchida K, Omori K, Takahashi K, Nomoto H, Kameda H, Cho KY, Terauchi Y, Atsumi T.

Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice.

Diebetes Obes Metab, in press.

IF: 6.57

  • 2021
  • 糖尿病・内分泌グループ
  • 欧文論文/原著